leadf
logo-loader
CSE:XPHY

XPhyto Therapeutics Corp.

Receive alerts
Market:
CSE
Market Cap:
$113.12 m
Price
1.95 CAD
Change
2.63%
52 weeks high
3.55
52 weeks low
0.73

In brief

XPhyto is a science-based cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto’s 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). XPhyto is pursuing additional opportunities in Germany including cultivation, processing, manufacturing, import, and distribution. 

Snapshot

The bioscience company and its exclusive diagnostic partner, 3a-Diagnostics GmbH, are developing a point-of-care lateral flow test to detect COVID-19 viral RNA in patient saliva